Junichi Omura Selected Research

Junichi Omura Research Topics

Disease

13	Pulmonary Hypertension 11/2023 - 09/2014
8	Pulmonary Arterial Hypertension 12/2023 - 01/2018
7	Hypoxia (Hypoxemia) 01/2021 - 01/2016
6	Inflammation (Inflammations) 11/2019 - 09/2014
5	Fibrosis (Cirrhosis) 01/2022 - 04/2016
4	Vascular Remodeling 03/2021 - 04/2017
4	Hypertrophy 01/2021 - 06/2014
2	Myocardial Infarction 12/2019 - 01/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2019 - 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2023
1	Lung Diseases (Lung Disease) 11/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Neoplasms (Cancer) 03/2021
1	Microvascular Rarefaction 10/2020
1	Parasitic Diseases (Parasitic Disease) 10/2019
1	Thoracic Aortic Aneurysm 11/2018
1	Rupture 11/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Thrombosis (Thrombus) 04/2017
1	Body Weight (Weight, Body) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Insulin Resistance 01/2017
1	Dysbiosis 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Cardiomegaly (Heart Hypertrophy) 05/2016
1	Right Ventricular Hypertrophy 06/2014

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2017
3	MonocrotalineIBA 01/2021 - 10/2020
3	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2021 - 09/2014
2	Endothelin Receptor AntagonistsIBA 12/2023 - 11/2023
2	Enhancer of Zeste Homolog 2 ProteinIBA 03/2021 - 10/2020
2	CytokinesIBA 01/2021 - 01/2019
2	Cyclophilin AIBA 01/2021 - 01/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020 - 01/2017
2	Selenoprotein PIBA 12/2019 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2016
2	rho-Associated KinasesIBA 05/2016 - 06/2014
1	Bosentan (Tracleer)FDA Link 12/2023
1	ambrisentan FDA Link 12/2023
1	macitentanIBA 12/2023
1	Prostaglandins IIBA 11/2023
1	clonidine-displacing substance (ClDS)IBA 11/2023
1	Thyroid Hormone-Binding ProteinsIBA 04/2022
1	Poly Adenosine Diphosphate RiboseIBA 04/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	prexasertibIBA 01/2022
1	celastrolIBA 01/2021
1	ApelinIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Semaxinib (SU5416)IBA 01/2021
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2020
1	pro-brain natriuretic peptide (1-76)IBA 10/2020
1	Long Noncoding RNAIBA 10/2020
1	E2F Transcription FactorsIBA 10/2020
1	Complement Factor D (Factor D)IBA 12/2019
1	EmetineIBA 11/2019
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 11/2019
1	SurvivinIBA 11/2019
1	ThrombospondinsIBA 10/2019
1	Mebendazole (Anti-Worm)FDA Link 10/2019
1	DisintegrinsIBA 10/2019
1	Metalloproteases (Metalloproteinases)IBA 10/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 11/2018
1	GTP-Binding Proteins (G-Protein)IBA 11/2018
1	Guanosine Diphosphate (GDP)IBA 11/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	ThrombomodulinIBA 04/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2017
1	Thrombin FDA Link 04/2017
1	AdiponectinIBA 01/2017
1	NitritesIBA 01/2017
1	NitratesIBA 01/2017
1	sodium nitrateIBA 01/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2016
1	Mitogen-Activated Protein Kinase 3IBA 05/2016
1	Matrix Metalloproteinases (MMPs)IBA 04/2016
1	Glycoproteins (Glycoprotein)IBA 04/2016
1	AMP-Activated Protein KinasesIBA 01/2016

Therapy/Procedure

4	Therapeutics 11/2023 - 01/2018
2	Patient Readmission 12/2019 - 01/2017